Sep 19, 2024
In this episode, host Shikha Jain, MD, speaks
with Brian Fiske about bringing biotech business
ideas to fruition, antibody drug conjugate developments and
more.
• Welcome to another exciting episode of Oncology
Overdrive 0:14
• About Fiske 0:21
• The interview 1:45
• How did you get to where you are today, and how did
you become interested in this specific area of health care?
2:06
• What is a timeline from start to finish to bringing
an innovative idea to fruition?
6:01
• How long does it take to form an actual company from
an idea? 11:20
• How do you figure out who you need on your team to
move an idea forward? 15:11
• Tell us about your previous positions at biotech
companies, and how did they help lead you into your current space?
20:22
• What excites you about your job? […] Why do you feel
the drive and desire to do this type of work?
24:40
• Where do you see the work at Mythic Therapeutics
doing in the next five to ten years for patient care?
26:27
• How can we work towards making sure this type of
innovative work is available and accessible to patients?
29:20
• If someone could only listen to the last few minutes
of this episode, what would you want them to take away?
31:16
• How to contact Fiske
32:12
• Thanks for listening
32:56
Brian Fiske is chief scientific officer and
co-founder of Mythic Therapeutics, a clinical-stage biotechnology
company committed to the development of next-generation
antibody-drug conjugate therapies for the treatment of a wide range
of cancers.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com.
Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/.
Follow Dr. Jain on X:
@ShikhaJainMD. Fiske can be reached via LinkedIn or
the Mythic Therapeutics
website.
Disclosures: Jain and Fiske report no relevant
financial disclosures.